{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2015"],"condition":["Colorectal cancer"],"disease":["Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2634755"],"location":["Japan"],"study_start_month":["10"],"repository":["ECRIN MDR"],"study_status":["Active, not recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Phase II clinical trial on systemic oxaliplatin chemotherapy plus molecular target therapy combined with hepatic arterial infusion (HAI) therapy for colorectal liver metastases","description":"Interventions: Period of intervension: 8 cycles of chemotherapy, mainly for 6 months.\nPrimary outcome(s): Two-year relative-free survival after liver surgery Overall survival\nStudy Design: Single arm Non-randomized","dates":{"creation":"2015-10-15"},"accession":"2634755","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000019466"]}}